Stock listing
Foresee Pharmaceuticals Co., Ltd.
Selected listing: 6576 · TPEX · TWD · TW
Foresee Pharmaceuticals Co., Ltd. (TPEx:6576), Health Technology. Latest release Jul 9, 2026: Foresee Pharmaceuticals Appoints Brian J. Groch as Chief…
- Ticker
- TPEx:6576
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- TPEx
- Currency
- TWD
About Foresee Pharmaceuticals Co., Ltd.
Foresee Pharmaceuticals Co., Ltd. is a publicly traded company on the Taiwan stock market under the ticker 6576. Foresee Pharmaceuticals focuses on developing innovative therapies to address unmet medical needs.
Latest news from Foresee Pharmaceuticals Co., Ltd.
Foresee Pharmaceuticals Appoints Brian J. Groch as Chief Commercial Officer to Spearhead Commercial Launch of FP-001 42 mg for Central Precocious Puberty
July 9, 2026
Foresee Pharmaceuticals Welcomes Positive CHMP Opinion Recommending Approval of CAMCEVI 21mg, 3-month strength in the European Union for Advanced Prostate Cancer
March 6, 2026
Foresee Pharmaceuticals Receives the Fourth Positive Recommendation from the DSMB to Continue the Casppian Ph3 Study, for Central Precocious Puberty (CPP)
February 4, 2026
Foresee Pharmaceuticals announces Global Licensing Agreement for MMP-12 Inhibitors with Primevera Therapeutics LLC
January 8, 2026
Foresee Pharmaceuticals announces the Casppian Phase 3 Study Meets Primary Efficacy Endpoint, Demonstrating Robust LH Suppression with 6-Month Dosing Interval of leuprolide mesylate
December 24, 2025
Research Foresee Pharmaceuticals Co., Ltd.
Foresee Pharmaceuticals Co., Ltd. company profile
View the public company page for Foresee Pharmaceuticals Co., Ltd. on 6ix.
Foresee Pharmaceuticals Co., Ltd. news
Read company news and market updates connected to Foresee Pharmaceuticals Co., Ltd..
Foresee Pharmaceuticals Co., Ltd. investor events
Find investor webinars, events, and replay context for Foresee Pharmaceuticals Co., Ltd..